Statement: the primary trial and the secondary trial report the same types of adverse events. non-neoplastic chronic respiratory system disorder is a non-neoplastic longstanding disorder of the respiratory system.
Primary_evidence: Adverse Events 1:   Total: 0/23 (0.00%)
Secondary_evidence: Adverse Events 1:   Total: 0/655 (0.00%) Adverse Events 2:   Total: 0/580 (0.00%)